These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 17474215)

  • 1. [Results of postpartum Rhesus prophylaxis 1967 to 1990].
    Schlensker KH; Krüger AA
    Geburtshilfe Frauenheilkd; 1996 Sep; 56(9):494-500. PubMed ID: 8991849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-D prophylaxis after abortions and interruptions].
    Maas DH
    Fortschr Med; 1979 Jan; 97(4):148-52. PubMed ID: 217809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of rhesus immunization in Australia. The first seven years.
    Davey MG
    Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of post-partum Rh-factor isoimmunization (experience of the Hospital 1st Gynecological-Obstetrical of the Mexican Institute of Social Security)].
    Cepeda AG; Sentíes L; Fiorelli FE; Garcete JA
    Ginecol Obstet Mex; 1975 Feb; 37(220):83-91. PubMed ID: 804430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization].
    Gherardi A
    Ig Mod; 1970; 63(1):47-56. PubMed ID: 4991878
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution of specific immunoglobulin anti-D to prophylaxis of haemolytic disease of the newborn].
    Bianu V; Zervos G; Kondi V; Balan S
    Rev Fr Gynecol Obstet; 1973 Oct; 68(10):569-71. PubMed ID: 17474215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current problems of blood group incompatibility in pregnancy].
    Wilken H
    Zentralbl Gynakol; 1988; 110(1):1-11. PubMed ID: 3281396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current problems in prophylactic treatment of Rh-erythroblastosis.
    J Reprod Med; 1971 May; 6(5):232-55. PubMed ID: 4937675
    [No Abstract]   [Full Text] [Related]  

  • 10. Fetal and neonatal cytopenias: what have we learned?
    Bussel JB
    Am J Perinatol; 2003 Nov; 20(8):425-31. PubMed ID: 14703590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
    Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
    BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.